- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.60 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x AZA: 8-AZAXANTHINE(Non-covalent)
AZA.1: 13 residues within 4Å:- Chain A: F.159, L.170, R.176, S.226, V.227, Q.228, N.254
- Chain B: Y.8, I.54, A.56, T.57, D.58
- Ligands: K.3
10 PLIP interactions:8 interactions with chain A, 2 interactions with chain B- Hydrogen bonds: A:R.176, A:R.176, A:V.227, A:Q.228, A:Q.228, A:N.254, B:T.57, B:D.58
- pi-Stacking: A:F.159, A:F.159
AZA.4: 13 residues within 4Å:- Chain A: Y.8, I.54, A.56, T.57, D.58
- Chain B: F.159, L.170, R.176, S.226, V.227, Q.228, N.254
- Ligands: K.6
10 PLIP interactions:8 interactions with chain B, 2 interactions with chain A- Hydrogen bonds: B:R.176, B:R.176, B:V.227, B:Q.228, B:Q.228, B:N.254, A:T.57, A:D.58
- pi-Stacking: B:F.159, B:F.159
AZA.7: 13 residues within 4Å:- Chain C: F.159, L.170, R.176, S.226, V.227, Q.228, N.254
- Chain D: Y.8, I.54, A.56, T.57, D.58
- Ligands: K.9
10 PLIP interactions:8 interactions with chain C, 2 interactions with chain D- Hydrogen bonds: C:R.176, C:R.176, C:V.227, C:Q.228, C:Q.228, C:N.254, D:T.57, D:D.58
- pi-Stacking: C:F.159, C:F.159
AZA.10: 13 residues within 4Å:- Chain C: Y.8, I.54, A.56, T.57, D.58
- Chain D: F.159, L.170, R.176, S.226, V.227, Q.228, N.254
- Ligands: K.12
10 PLIP interactions:8 interactions with chain D, 2 interactions with chain C- Hydrogen bonds: D:R.176, D:R.176, D:V.227, D:Q.228, D:Q.228, D:N.254, C:T.57, C:D.58
- pi-Stacking: D:F.159, D:F.159
- 8 x K: POTASSIUM ION(Non-covalent)
K.2: 6 residues within 4Å:- Chain A: I.88, Y.91, N.92, I.94, H.95, E.136
3 PLIP interactions:3 interactions with chain A- Metal complexes: A:I.88, A:Y.91, A:I.94
K.3: 5 residues within 4Å:- Chain A: N.254, H.256, G.286
- Chain B: T.57
- Ligands: AZA.1
No protein-ligand interaction detected (PLIP)K.5: 6 residues within 4Å:- Chain B: I.88, Y.91, N.92, I.94, H.95, E.136
3 PLIP interactions:3 interactions with chain B- Metal complexes: B:I.88, B:Y.91, B:I.94
K.6: 5 residues within 4Å:- Chain A: T.57
- Chain B: N.254, H.256, G.286
- Ligands: AZA.4
No protein-ligand interaction detected (PLIP)K.8: 6 residues within 4Å:- Chain C: I.88, Y.91, N.92, I.94, H.95, E.136
3 PLIP interactions:3 interactions with chain C- Metal complexes: C:I.88, C:Y.91, C:I.94
K.9: 5 residues within 4Å:- Chain C: N.254, H.256, G.286
- Chain D: T.57
- Ligands: AZA.7
No protein-ligand interaction detected (PLIP)K.11: 6 residues within 4Å:- Chain D: I.88, Y.91, N.92, I.94, H.95, E.136
3 PLIP interactions:3 interactions with chain D- Metal complexes: D:I.88, D:Y.91, D:I.94
K.12: 5 residues within 4Å:- Chain C: T.57
- Chain D: N.254, H.256, G.286
- Ligands: AZA.10
No protein-ligand interaction detected (PLIP)- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Giffard, M. et al., Surfactant Poloxamer 188 as a New Crystallizing Agent for Urate Oxidase. Cryst.Growth Des. (2009)
- Release Date
- 2010-02-23
- Peptides
- Uricase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.60 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x AZA: 8-AZAXANTHINE(Non-covalent)
- 8 x K: POTASSIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Giffard, M. et al., Surfactant Poloxamer 188 as a New Crystallizing Agent for Urate Oxidase. Cryst.Growth Des. (2009)
- Release Date
- 2010-02-23
- Peptides
- Uricase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A